Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP-4 complex subunit sigma-1 (AP4S1) is the small, sigma-1 subunit of the heterotetrameric AP-4 adaptor protein complex. The AP-4 complex consists of two large chains (beta-4, epsilon-4), one medium chain (mu-4), and this small sigma-4 chain (AP4S1). These adaptor protein complexes are essential for sorting integral membrane proteins at key stages of the cell’s endocytic and secretory trafficking pathways. AP-4, in particular, mediates export of transmembrane cargo, including autophagy protein ATG9A, from the trans-Golgi network. Unlike other AP complexes, AP-4 is less abundant but ubiquitously expressed, supporting its specialized but critical role in all cell types. Mutations in any AP-4 subunit, including AP4S1, cause AP-4-deficiency syndrome—a hereditary spastic paraplegia with neurodevelopmental impairment. The AP-4 complex assembly is facilitated by the chaperone AAGAB, which stabilizes the AP-4 epsilon and sigma-4 subunits (AP4S1) for proper complex formation. There are no known drugs that directly target AP4S1, nor established mechanisms, biomarkers, or safety concerns relevant to therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP-4 complex subunit sigma-1 (AP4S1).